Diarymethyl and related compounds

Details Diarymethyl and related compounds Diarymethyl and related compounds

2007-11-13

2010-11-09

Seaman, D. Margaret (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

active

07829728

ABSTRACT:
This invention provides compounds of formula I:wherein R1, R2, R3, R4, R5, R6, R7, Ar1, Ar2, E, a, b, c and z are as defined in the specification, or a pharmaceutically acceptable salt or solvate or stereoisomer thereof. The compounds of this invention possess both β2adrenergic receptor agonist and muscarinic receptor antagonist activity and therefore, such compounds are useful for treating pulmonary disorders, such as chronic obstructive pulmonary disease and asthma.

REFERENCES:
patent: 3984557 (1976-10-01), Welstead, Jr.
patent: 4002766 (1977-01-01), Welstead, Jr.
patent: 4594343 (1986-06-01), Shanklin, Jr.
patent: 4810713 (1989-03-01), Yanni et al.
patent: 4894219 (1990-01-01), Baker et al.
patent: 4950674 (1990-08-01), Yanni et al.
patent: 5070087 (1991-12-01), Teng et al.
patent: 5096890 (1992-03-01), Cross et al.
patent: 5233053 (1993-08-01), Cross et al.
patent: 5340831 (1994-08-01), Cross et al.
patent: 5607950 (1997-03-01), Alker et al.
patent: 5932594 (1999-08-01), Cross et al.
patent: 6268533 (2001-07-01), Gao et al.
patent: 6362371 (2002-03-01), Moran et al.
patent: 6433027 (2002-08-01), Bozung et al.
patent: 6576793 (2003-06-01), Moran et al.
patent: 6593497 (2003-07-01), Choi et al.
patent: 6653323 (2003-11-01), Moran et al.
patent: 6670376 (2003-12-01), Moran et al.
patent: 6693202 (2004-02-01), Aggen et al.
patent: 6713651 (2004-03-01), Moran et al.
patent: 6747043 (2004-06-01), Moran et al.
patent: 7317102 (2008-01-01), Mammen et al.
patent: 25 58 501 (1976-07-01), None
patent: 0 178 946 (1986-04-01), None
patent: 0 178 947 (1986-04-01), None
patent: 0 235 463 (1987-09-01), None
patent: 0 388 054 (1990-09-01), None
patent: WO 91/09013 (1991-06-01), None
patent: WO 98/54167 (1998-12-01), None
patent: WO 99/64031 (1999-12-01), None
patent: WO 99/64035 (1999-12-01), None
patent: WO 99/64043 (1999-12-01), None
patent: WO 2004/074276 (2004-09-01), None
Office Action from U.S. Appl. No. 10/813,745 (Feb. 13, 2007).
Cale et al., “A Series of Central Nervous System Stimulants Based on the 4-Substituted 3,3-Diphenyl-2-pyrrolidinone Skeleton. II”, J. Med. Chem., 10(2), pp. 214-222 (1967).
Glaxo Wellcome PLC, New long acting β2agonists', Expert Opin. Ther. Patents, 13(2), pp. 273-277 (2003).
Graul et al., “Darifenacin”, Drugs of the Future, 21(11), pp. 1105-1108 (1996).
Zlotos at al., “Muscarinic receptor agonists and antagonists”, Exp. Opin. Ther. Patents, 9(8), pp. 1029-1053 (1999).

Affiliated with

Also associated with

Rating

Diarymethyl and related compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Diarymethyl and related compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diarymethyl and related compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4203337